Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Vanda Pharmaceuticals
Phase 3
150
California, Tennessee
2026-09
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 1
90
Florida
2026-08-20
Recruiting
Eli Lilly and Company
Phase 2
1,431
Arizona, California, Colorado, Connecticut, Florida, Idaho, Illinois, Indiana
2026-03-26
Active, closed
AltruBio Inc.
Phase 1
24
Florida
2025-11-17
Not yet open
Rubix LS
Phase 4
150
Massachusetts
2025-07-16
Recruiting
Mirador Therapeutics, Inc.
Phase 2
140
Alabama, Arizona, Arkansas, Colorado, Florida, Georgia, Illinois, Louisiana
2025-06-26
Recruiting
Xencor, Inc.
Phase 1/2
270
Arizona, California, Florida, Kentucky, Mississippi, New York, North Carolina, Ohio
2024-10-10
Active, closed
AbbVie
Phase 3
1,242
California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kansas
2018-08-28
Active, closed
AbbVie
Phase 3
950
Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois
2017-01-31
Active, closed
AbbVie
Observational
8,250
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida
2013-04-29